Clinical trials in oncology & hematology

Our clinical research associates (CRAs) in oncology and hematology are highly trained professionals who ensure integrity and commitment to excellence.

Pepgra gives you clinical solutions fast. Deep oncology and hematology experience at every aspect of your trial through our array of capabilities to derive your output.

Pepgra experts will give you right data at the earliest, to enhance the results of your oncology drug development tests. We have the focus, breadth of expertise and ambidexterity to get you results fast.

The following are the merits of our oncology clinical research:

  • Availability of native experts
  • Extensive experience in complex clinical trials
  • Expert assigned from the preclinical till phase 3 trial
  • Knowledge of drugs and tumor varieties
  • Knowledge of diseases and investigational agents
  • Experience in managing dose acceleration and determining max tolerated dose
  • Knowledge of audits in safety
  • Affinity with investigators and experts
  • Recruitment—to source the appropriate group of patients for trial

Also, Pepgra clinics are equipped to provide results for device and drug manufacturers in the following areas:

  • Balloon catheters
  • Stents
  • Vascular grafts
  • Blood Vessels
  • Tourniquets
  • Embolic filters
  • Vascular clamps

Call us to find out how our CRAs can help you a specific area or if you want to participate in a clinical trial.

pepgra company-brochure

Biostatistical capabilities

We give solutions to the healthcare, pharmaceuticals and food industries to boost sophistication of statistical elements in their study…. Read More
pepgra whitepapper
White Paper

Clinical evaluations

Clinical Evaluation Report (CER) in a more Stringent Regulatory Environment- Now, subject to more intense scrutiny by Noti¬fied Bodies…
Big Data in IoT for Healthcare Read More
pepgra case-study

Medical writing

The requirements for medical writing are witnessing continuous growth influenced in good portion by the mounting government scrutiny and… Read More

Have a business query? Let’s talk.

Subscribe to cro.pepgra Newsletter